Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.

MLA

Ilerhunmwuwa, Nosakhare Paul, et al. “Demographics and Outcomes of Hemoglobin Genotype in Hospitalized Patients with COVID-19 and Sickle Cell Disease in the United States.” European Journal of Haematology, vol. 111, no. 4, Oct. 2023, pp. 611–19. EBSCOhost, https://doi.org/10.1111/ejh.14054.

APA

Ilerhunmwuwa, N. P., Inyang, L., Wasifuddin, M., Aiwuyo, H., Tahir, M., Hakobyan, N., Ankah, P., Torere, B. E., Amaechi, U. M., Rayapureddy, A. K., & Wang, J. C. (2023). Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States. European Journal of Haematology, 111(4), 611–619. https://doi.org/10.1111/ejh.14054

Chicago

Ilerhunmwuwa, Nosakhare Paul, Lawrence Inyang, Mustafa Wasifuddin, Henry Aiwuyo, Muhammad Tahir, Narek Hakobyan, Paul Ankah, et al. 2023. “Demographics and Outcomes of Hemoglobin Genotype in Hospitalized Patients with COVID-19 and Sickle Cell Disease in the United States.” European Journal of Haematology 111 (4): 611–19. doi:10.1111/ejh.14054.